Related Experiment Video
Updated: Mar 30, 2026

09:17
Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
18.9K
Hypoxia-inducible factor 3 biology: complexities and emerging themes
1Department of Molecular, Cellular, and Developmental Biology, University of Michigan, Ann Arbor, Michigan cduan@umich.edu.
American Journal of Physiology. Cell Physiology
|November 13, 2015
Summary
Hypoxia-inducible factor 3 (HIF-3) has multiple variants with diverse functions. Some HIF-3 variants activate transcription, while others inhibit HIF-1/2, offering new therapeutic avenues.
Area of Science:
- Molecular Biology
- Cellular Biology
- Genetics
Background:
- The hypoxia-inducible factor (HIF) family regulates cellular responses to low oxygen.
- HIF-1 and HIF-2 are well-established transcriptional regulators, but HIF-3 function is less understood.
- The HIF-3α gene generates diverse variants through alternative promoters, transcription start sites, and splicing.
Purpose of the Study:
- To explore the diverse functions and regulatory mechanisms of HIF-3α variants.
- To identify target genes regulated by HIF-3α.
- To investigate the potential of HIF-3 variants in therapeutic strategies.
Main Methods:
- Analysis of HIF-3α gene expression across different tissues and developmental stages.
- Identification of HIF-3α target genes through molecular assays.
- Functional characterization of various HIF-3α variants, including full-length and truncated forms.
Main Results:
- HIF-3α variants exhibit distinct expression patterns and are differentially regulated.
- Full-length HIF-3α acts as a transcription activator, initiating a unique hypoxic response.
- Certain HIF-3α variants function as dominant-negative regulators or compete with HIF-1/2 for HIF-β binding.
Conclusions:
- HIF-3α variants possess diverse and sometimes opposing functions in hypoxia response.
- Understanding HIF-3 biology is crucial for deciphering complex oxygen-sensing pathways.
- HIF-3α variants represent potential targets for novel therapeutic interventions.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
4.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
Hypoxia
2.5K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.5K
General Transcription Factors
7.6K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
7.6K
Transcription Factors
83.9K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
83.9K
Transcription Factors
26.9K
26.9K
Adaptive Mechanisms in Cancer Cells
7.4K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K

